Cereius aims to improve the lives & survival of patients facing solid tumor brain metastasis through the use of personalized and highly targeted radiotherapy.
Cereius, Inc. Announces $6.75 Million Financing Proceeds to Advance Novel Therapies for Treating Solid Tumor Brain Metastasis story.cd/AAJojy via @PRWeb
Duke startup Cereius (Michael Zalutsky, Prof of Radiology & Kimberly Blackwell, Adjunct Prof of Med) just raised $6.7M to advance Duke-invented therapies for treating solid tumor brain metastases. ow.ly/n0Qo30lhSoY